New Podcast Episode – ELSI Dialogues: Artificial Intelligence in South-Eastern Asia – The Indonesian National Artificial Intelligence Strategy on Ethics and Policy

This article is 296 words – a two-minute read.

“AI systems need to be human centric, they should serve humanity and the common good”

Episode 26 takes you to a webinar on developing strategies for a trustworthy AI explored at the example of South-eastern Asia. After a quick introduction on how the European Union approaches this challenge, Thilma Komaling, one of the authors of Indonesia’s strategy on Artificial Intelligence, takes you her home country where AI-assisted tools already help to improve broad access to health care.

Thilma shares her more than 20 years of experience in policy development here in this webinar organised by the BBMRI-ERIC ELSI team. ELSI specialises in addressing ethical, legal and societal implications of biobanking and the responsible use of sensitive data and new technologies.

The transformative potential of AI will not stop at national borders and so we can all profit from exchanging our experiences to use this technology for the best of society. Together with Thilma, Ilaria Colussi, one of BBMRI-ERIC’s legal experts, explores the common ground between the EU’s and Indonesia’s approach to a trustworthy AI.

“We need something very close to to the heart of the people of Indonesia, because this is something that needs to be originally from Indonesia. What we believe and what we want to carry forward as a nation.”

Indondesia explores a strategy that builds on the country’s core values to find a human-centered approach to responsibly integrate this highly transformative technology into the daily live. One example is Halodoc, an AI-assisted app, that allows Indonesia’s citizens access to health-related advise and information even in the remotest areas of the large, archipelagic country with its hundreds of languages.

BBMRI-ERIC Podcast

These episodes aim to give you insights from the congress that took place in Prague from 19-22 May 2026.

This episode, recorded on 21 May, introduces you to Aneta Tyszkiewicz who is Director, Science and Regulatory at the European Federation of Pharmaceutical Industries and Associations (EFPIA). They represent the R&D-based pharmaceutical industry in Europe. Aneta leads EFPIA’s policy and advocacy on data, real-world evidence and emerging technologies, including biotechnologies.

Her work focuses on advancing the digital transformation of healthcare in Europe to enable the development of innovative, trusted solutions that deliver tangible benefits for patients.

Aneta’s keynote was titled ‘From scientific excellence to industrial leadership: Strengthening Europe’s attractiveness for research and innovation through the EU Biotech Act’. Listen to this interview to hear why the Act has the potential to unlock Europe’s biotechnology research potential, support new patient therapies and why it is relevant for the biobanking community.

Links: